Durable Response to Brentuximab Vedotin Plus Cyclophosphamide, Doxorubicin, and Prednisone (BV-CHP) in a Patient with CD30-Positive PTCL Arising as a Post-Transplant Lymphoproliferative Disorder (PTLD). - Hong, Jennifer; Johnson, William T.; Kartan, Saritha; Gonsalves, Anitha S.; Fenkel, Jonathan M.; Gong, Jerald Z.; Porcu, Pierluigi (Current Oncology, 2021)